Orbillion Bio
Premium cultivated meat at low cost
Intro to Orbillion Bio: https://www.youtube.com/watch?v=wAf21WXxnhw
Orbillion is making cultivated beef at scale using advanced computational models to rapidly optimize the bioprocess and reduce cost. With Orbillion’s proprietary bioware, they can precisely control the microenvironment that the meat cells need. This supercharges cell growth without the need for GMO, serum, or expensive growth factors, enabling a cost of $4 per kg at commercial scale.
Orbillion’s technology addresses the industry's two main challenges: cost and scale-up. Its integrated bioprocess platform allows Orbillion to produce at a commercial level anywhere globally within two weeks in an asset-light fashion. Partnerships with two global food companies of combined $280B revenue, and a European partner have fast-tracked commercialization in the $211B ground beef market. Founders Dr. Patricia Bubner and Samet Yildirim are the only industry founders with scale-up experience in mammalian cells from the biopharma industry. Orbillion is backed by The Venture Collective, Y Combinator, At One Ventures, Venture Souq, and Metaplanet among others.
Latest News
Dec 13, 2022
Orbillion Bio
Active Founders
Patricia Bubner, Founder
Patricia is a scientist and engineer with a background in high-throughput screening, automation, process analytics and development. She has a broad industry experience in biopharma and clean energy (Boehringer Ingelheim, Sila Nanotechnologies). She has an MSc and PhD in chemistry and biotechnology. During her postdoc at UC Berkeley, she co-founded themilletproject.org, that aimed at diversifying agriculture and our diet through cultivation and consumption of lesser-known grains such as millets.
Samet Yildirim, Founder
Samet has 10+ years of experience in commercializing biotechnologies. Samet was the Global Head of Innovation in the Boehringer Ingelheim's Biopharma Business Unit where he led the development and commercialization of biomanufacturing technologies. Prior to that, Samet held various positions within responsibilities for product innovation and business development in life science companies. He received a BSc in Biology and an MSc in Biophysics and business masters (MBS) in bioprocessing.
